Taiwan's digital health brand H2U enters South Korean market to expand offerings

H2U, Taiwan's premier digital health brand, has announced another successful round of funding this year after receiving ...

November 14, 2023 | Tuesday | News
Taiwan's medtech firm Suglasses raises $6.5M to expand augmented reality surgical navigation system

Taiwan-based medtech startup Surglasses recently announced successful completion of a $6.5 million Pre-A funding round. ...

November 10, 2023 | Friday | News
“Computer-aided diagnosis provided by AI needs to gain trust from doctors”

How will ITRI's Point-of-Care AI-DR system address critical healthcare needs related to diabetic retinopathy and diabeti...

October 31, 2023 | Tuesday | Opinion
New Jersey's life sciences trade association BioNJ inks MoU with Taiwan BIO

New Jersey Governor Phil Murphy recently visited Hsinchu Biomedical Science Park in Taiwan during the Choose New Jersey ...

October 27, 2023 | Friday | News
Taiwanese firm TaiGen Biopharma to develop and commercialise new drug in Malaysia and Singapore

TaiGen Biopharmaceuticals Holdings has announced that TaiGen Biotechnology, a subsidiary company of TaiGen, has signed a...

October 11, 2023 | Wednesday | News
2nd Global Biotech Taiwan CEO Awards takes place in Taipei

The race was on among young biotech Chief Executive Officers (CEOs) for top position in 2023 Best Bio CEO awards organis...

October 10, 2023 | Tuesday | News
Taiwan approves first and only treatment for rare genetic disorder

CANbridge Pharmaceuticals, a global biopharmaceutical company with a foundation in China, has announced the marketi...

October 10, 2023 | Tuesday | News
Taiwan's medtech startup Flat Medical secures funding for global market expansion

Flat Medical, a Taiwan-based medtech company specialising in innovative safety solutions for anesthesia, pain medicine, ...

October 3, 2023 | Tuesday | News
Taiwan launches National Lung Cancer Early Detection Programme

The Taiwan National Lung Cancer Early Detection Programme has detected 85 percent of lung cancer cases at either a phase...

September 16, 2023 | Saturday | News
Menarini inks €5.5 M deal with Astellas for rheumatoid arthritis treatment in Taiwan & few South East Asian markets

Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Japanese firm Astellas Pharma fo...

September 13, 2023 | Wednesday | News
Bristol Myers Squibb inks $50 M deal to treat immune-mediated diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Compan...

September 6, 2023 | Wednesday | News
BIO Asia-Taiwan 2023: Embracing Asian Dynamics around precision health and CDMO

The Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BIO) ignited Tai...

August 31, 2023 | Thursday | Analysis
Taiwan-based Formosa Pharma inks $86 M worth ophthalmology deal with American firm Eyenovia

Taiwan-based Formosa Pharmaceutical has entered into a licensing agreement with Eyenovia, whereby Eyenovia obtains exclu...

August 21, 2023 | Monday | News
ABVC BioPharma to open new facility in Taiwan for manufacturing retinal surgery device

US-based ABVC BioPharma has received approval from the Science Park Administration in Taiwan to establish a pilot Good M...

August 7, 2023 | Monday | News
Bora Pharmaceuticals unveils new facility in Taiwan for manufacturing ophthalmic products

Bora Pharmaceuticals, a leading contract development and manufacturing organisation (CDMO), has announced the opening of...

August 4, 2023 | Friday | News
Taiwan BioMed Industry Eyes $32B

Taiwan's ‘5+2’ Innovative Industries Plan prioritises biomedicine. The government approved the Biomedical In...

August 2, 2023 | Wednesday | Analysis
Taiwan's Lotus pharma to market Vazkepa in 10 Asian countries to reduce cardiovascular risk

Taiwan's Lotus Pharmaceuticals and Ireland's Amarin Corporation have entered into a long-term exclusive partnership to d...

August 2, 2023 | Wednesday | News
“Asia-Pacific represents a vast and relatively untapped market for Digital Pathology”

How does your innovative technology differ from traditional pathology methods? JelloX Biotech is revolutionising cancer...

August 2, 2023 | Wednesday | Opinion